Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment

By Morotti Matteo   Valenzano Menada Mario   Venturini Pier Luigi   Ferrero Simone  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 6, 2011-06 ,pp. : 707-720

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic Optimisation of the Treatment of Cancer with High Dose Zidovudine

By Danesi R.  

Clinical Pharmacokinetics, Vol. 34, Iss. 2, 1998-02 ,pp. : 173-180

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Optimisation of the Treatment of Neurocysticercosis

By Sotelo J.   Jung H.  

Clinical Pharmacokinetics, Vol. 34, Iss. 6, 1998-06 ,pp. : 503-515

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Optimisation of Treatment with Oral Etoposide

By Toffoli G.  

Clinical Pharmacokinetics, Vol. 43, Iss. 7, 2004-01 ,pp. : 441-466

Adis International

Access to resources Recommend Favorite

Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer

By Okamoto Isamu   Miyazaki Masaki   Morinaga Ryotaro   Kaneda Hiroyasu   Ueda Shinya   Hasegawa Yoshikazu   Satoh Taroh   Kawada Akira   Fukuoka Masahiro   Fukino Koichi   Tanigawa Takahiko   Nakagawa Kazuhiko  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 844-853

Springer Publishing Company

Access to resources Recommend Favorite